Bone Biologics Stock (NASDAQ: BBLG) stock price, news, charts, stock research, profile.
Open | $2.040 |
Close | $2.130 |
Volume / Avg. | 21.334K / 270.653K |
Day Range | 2.020 - 2.260 |
52 Wk Range | 2.030 - 86.808 |
Market Cap | $1.776M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 39 |
Short Interest | 3.67% |
Days to Cover | 1 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Bone Biologics (NASDAQ: BBLG) through any online brokerage.
Other companies in Bone Biologics’s space includes: NeuBase Therapeutics (NASDAQ:NBSE), Dermata Therapeutics (NASDAQ:DRMA), Quoin Pharmaceuticals (NASDAQ:QNRX), Qualigen Therapeutics (NASDAQ:QLGN) and Cyclacel Pharmaceuticals (NASDAQ:CYCC).
The latest price target for Bone Biologics (NASDAQ: BBLG) was reported by EF Hutton on Thursday, April 13, 2023. The analyst firm set a price target for 2.25 expecting BBLG to rise to within 12 months (a possible 11.39% upside). 2 analyst firms have reported ratings in the last year.
The stock price for Bone Biologics (NASDAQ: BBLG) is $2.02 last updated March 27, 2024 at 4:20 PM EDT.
There are no upcoming dividends for Bone Biologics.
Bone Biologics does not have any upcoming earnings scheduled.
There is no upcoming split for Bone Biologics.
Bone Biologics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.